727 related articles for article (PubMed ID: 30590748)
1. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
Heiligenhaus A; Klotsche J; Tappeiner C; Sengler C; Niewerth M; Liedmann I; Hoeft S; Walscheid K; Lavric M; Foell D; Minden K
Rheumatology (Oxford); 2019 Jun; 58(6):975-986. PubMed ID: 30590748
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
4. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany.
Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K
Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
Magli A; Forte R; Navarro P; Russo G; Orlando F; Latanza L; Alessio M
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1601-6. PubMed ID: 23446556
[TBL] [Abstract][Full Text] [Related]
6. Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
Lee JJY; Duffy CM; Guzman J; Oen K; Barrowman N; Rosenberg AM; Shiff NJ; Boire G; Stringer E; Spiegel L; Morishita KA; Lang B; Reddy D; Huber AM; Cabral DA; Feldman BM; Yeung RSM; Tucker LB; Watanabe Duffy K;
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1436-1443. PubMed ID: 30320957
[TBL] [Abstract][Full Text] [Related]
7. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
[TBL] [Abstract][Full Text] [Related]
8. Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study.
Siiskonen M; Hirn I; Pesälä R; Ohtonen P; Hautala N
Pediatr Rheumatol Online J; 2023 Jun; 21(1):56. PubMed ID: 37322490
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
Trials; 2014 Jan; 15():14. PubMed ID: 24405833
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).
Yasumura J; Yashiro M; Okamoto N; Shabana K; Umebayashi H; Iwata N; Okura Y; Kubota T; Shimizu M; Tomiita M; Nakagishi Y; Nishimura K; Hara R; Mizuta M; Yasumi T; Yamaide F; Wakiguchi H; Kobayashi M; Mori M
Pediatr Rheumatol Online J; 2019 Apr; 17(1):15. PubMed ID: 30975163
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW;
N Engl J Med; 2017 Apr; 376(17):1637-1646. PubMed ID: 28445659
[TBL] [Abstract][Full Text] [Related]
12. [New therapy approaches, better outcomes? : Results from inception cohorts for patients with juvenile idiopathic arthritis].
Sengler C
Z Rheumatol; 2019 Sep; 78(7):610-619. PubMed ID: 31127369
[TBL] [Abstract][Full Text] [Related]
13. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.
Rypdal V; Glerup M; Songstad NT; Bertelsen G; Christoffersen T; Arnstad ED; Aalto K; Berntson L; Fasth A; Herlin T; Ekelund M; Peltoniemi S; Toftedal P; Nielsen S; Leinonen S; Bangsgaard R; Nielsen R; Rygg M; Nordal E;
Ophthalmology; 2021 Apr; 128(4):598-608. PubMed ID: 32866542
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.
Nordal E; Rypdal V; Christoffersen T; Aalto K; Berntson L; Fasth A; Herlin T; Nielsen S; Peltoniemi S; Straume B; Zak M; Rygg M;
Pediatr Rheumatol Online J; 2017 Aug; 15(1):66. PubMed ID: 28821293
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, Treatment, and Outcomes of Juvenile Idiopathic Arthritis-Associated Uveitis: A Multi-Institutional Study in Taiwan.
Wu PY; Kang EY; Chen WD; Chiang WY; Wu CH; Wu CY; Chen KJ; Wu WC; Chou HD; Chao AN; Hwang YS
Ocul Immunol Inflamm; 2023 Dec; 31(10):2009-2017. PubMed ID: 36696667
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial.
Horton S; Jones AP; Guly CM; Hardwick B; Beresford MW; Lee RW; Dick AD; Ramanan AV
Am J Ophthalmol; 2019 Nov; 207():170-174. PubMed ID: 31201796
[TBL] [Abstract][Full Text] [Related]
17. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
[TBL] [Abstract][Full Text] [Related]
18. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
[TBL] [Abstract][Full Text] [Related]
19. The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
Kotaniemi K; Sihto-Kauppi K; Salomaa P; Säilä H; Ristolainen L; Kauppi M
Clin Exp Rheumatol; 2014; 32(1):143-7. PubMed ID: 24351424
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
Papadopoulou M; Zetterberg M; Oskarsdottir S; Andersson Grönlund M
Acta Ophthalmol; 2017 Nov; 95(7):741-747. PubMed ID: 28205413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
